These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1623637)

  • 21. Challenges faced by the pharmaceutical industry: training graduates for employment in pharmaceutical R&D.
    Mooney KG
    Eur J Pharm Sci; 2001 Feb; 12(4):353-9. PubMed ID: 11231101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generic drug prices and policy in Australia: room for improvement? a comparative analysis with England.
    Mansfield SJ
    Aust Health Rev; 2014 Feb; 38(1):6-15. PubMed ID: 24480618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The power of genomics to transform the biotechnology industry.
    Haseltine WA
    Nat Biotechnol; 1998 May; 16 Suppl():25-7. PubMed ID: 9591259
    [No Abstract]   [Full Text] [Related]  

  • 24. Decline in economic returns from new drugs raises questions about sustaining innovations.
    Berndt ER; Nass D; Kleinrock M; Aitken M
    Health Aff (Millwood); 2015 Feb; 34(2):245-52. PubMed ID: 25646104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of government as it affects the pharmaceutical industry and profession.
    HOLLAND AH
    Am J Pharm Sci Support Public Health; 1955 May; 127(5):158-63. PubMed ID: 13354727
    [No Abstract]   [Full Text] [Related]  

  • 26. The state of innovation in drug development.
    Kola I
    Clin Pharmacol Ther; 2008 Feb; 83(2):227-30. PubMed ID: 18202690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eurofile. Private-public drive to cut delays in drug development.
    Mundell I
    Eur J Cancer; 2008 Jan; 44(2):169. PubMed ID: 18335586
    [No Abstract]   [Full Text] [Related]  

  • 28. The Asian currency crisis and the Australian health industry.
    Barraclough S
    Aust Health Rev; 1998; 21(4):40-53. PubMed ID: 10537568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmaceutical reference pricing in Germany: definition of therapeutic groups, price setting through regression procedure and effects].
    Stargardt T; Schreyögg J; Busse R
    Gesundheitswesen; 2005 Jul; 67(7):468-77. PubMed ID: 16103970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting Unconscionable Prescription-Drug Prices - Maryland's Anti-Price-Gouging Law.
    Greene JA; Padula WV
    N Engl J Med; 2017 Jul; 377(2):101-103. PubMed ID: 28591520
    [No Abstract]   [Full Text] [Related]  

  • 31. Fundamental problems lie ahead in the drug discovery and commercialization process: restructuring of the pharmaceutical industry and an improved partnership with academia are required.
    Brewer GJ
    J Investig Med; 2006 Sep; 54(6):291-302. PubMed ID: 17191351
    [No Abstract]   [Full Text] [Related]  

  • 32. Best drug prices won nationally.
    Kuntz E
    Mod Healthc; 1980 Oct; 10(10):28-9. PubMed ID: 10248725
    [No Abstract]   [Full Text] [Related]  

  • 33. Venturing into drug discovery.
    Steinmetz M
    Nat Biotechnol; 1998 May; 16 Suppl():17. PubMed ID: 9591255
    [No Abstract]   [Full Text] [Related]  

  • 34. A few specialty drug prices fall--all generics.
    Manag Care; 2008 Dec; 17(12):46. PubMed ID: 19127766
    [No Abstract]   [Full Text] [Related]  

  • 35. Time to fix the price fix.
    Earl-Slater A
    Health Serv J; 1997 Nov; 107(5578):22-3. PubMed ID: 10174008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibacterial drug discovery: is it all downhill from here?
    Projan SJ; Shlaes DM
    Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():18-22. PubMed ID: 15522036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fair pricing or pricing for profit?
    Sibbald B
    CMAJ; 2017 May; 189(20):E733-E734. PubMed ID: 28536135
    [No Abstract]   [Full Text] [Related]  

  • 38. Biotechnology partnerships--medicine for an ailing industry?
    DeLamarter J
    Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
    [No Abstract]   [Full Text] [Related]  

  • 39. Will lower drug prices jeopardize drug research? A policy fact sheet.
    Light DW; Lexchin J
    Am J Bioeth; 2004; 4(1):W1-4. PubMed ID: 15035915
    [No Abstract]   [Full Text] [Related]  

  • 40. AIDS drugs & the pharmaceutical industry: a need for reform.
    Griffin MT
    Am J Law Med; 1991; 17(4):363-410. PubMed ID: 1812767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.